MedPath

Fast Food, Fatigue, and Inflammation

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Other: Saturated Fat Meal
Other: Oleic Sunflower Oil Meal
Registration Number
NCT04247763
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Brief Summary

This double-blind, randomized crossover trial assessed inflammation and fatigue following a fast-food-type meal (saturated fat) compared to a healthier meal (monounsaturated fat) in breast cancer survivors and benign controls (women who had an initial abnormal test for breast cancer).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
58
Inclusion Criteria
  • We recruited a subset of a larger parent longitudinal observational study to participate in this study. Initially, participants were recruited following an abnormal mammogram, which resulted in either a malignant (cancer group) or benign (non-cancer control group) diagnosis.
Exclusion Criteria
  • A history of any prior cancer except basal or squamous cell, chronic obstructive pulmonary disease, evidence of liver or kidney failure, symptomatic ischemic heart disease, significant visual or auditory problems, cognitive impairment, major medical conditions involving the immune system such as diabetes, autoimmune and/or inflammatory diseases including rheumatoid arthritis and ulcerative colitis, alcohol or drug abuse, marked and recurrent gastrointestinal problems, or regular use of medications with major immunological consequences, e.g., steroids.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Arm 1 (Saturated Fat Meal, Oleic Sunflower Oil Meal)Saturated Fat Meal-
Arm 2 (Oleic Sunflower Oil Meal, Saturated Fat Meal)Oleic Sunflower Oil Meal-
Arm 1 (Saturated Fat Meal, Oleic Sunflower Oil Meal)Oleic Sunflower Oil Meal-
Arm 2 (Oleic Sunflower Oil Meal, Saturated Fat Meal)Saturated Fat Meal-
Primary Outcome Measures
NameTimeMethod
Post-Meal Change in C-reactive ProteinBlood samples were obtained before the meal (baseline) as well as 2, 4, and 7 hours post-meal

Serum CRP was obtained from blood drawn before the meal as well as 2, 4, and 7 hours post-meal. It was measured with the Vascular Injury Panel 2 Multispot Kit on an MSD Imager 2400 (both Meso Scale Discovery, Rockville, MD, USA), following kit instructions.

Fatigue at Follow-Up VisitsThe survey was administered upon admission to the Clinical Research Center before the meal at both visits and at 18- and 30-month follow-up visits.

The 30-item Multidimensional Fatigue Symptom Inventory-Short form assesses behavioral, cognitive, physical, and affective expressions of fatigue. It provides a very good measure of the multidimensional aspects of fatigue, allows for comparisons between fatigued and non-fatigued individuals, and has subscales measuring general, physical, emotional, mental, and vigor aspects of fatigue, as well as a total score.

Change in Vascular cell adhesion molecule-1Blood samples were obtained before the meal (baseline) as well as 2, 4, and 7 hours post-meal

sVCAM-1 was obtained from blood drawn before the meal as well as 2, 4, and 7 hours post-meal. It was measured with the Vascular Injury Panel 2 Multispot Kit on an MSD Imager 2400 (both Meso Scale Discovery, Rockville, MD, USA), following kit instructions.

Post-Meal Change in Serum Amyloid ABlood samples were obtained before the meal (baseline) as well as 2, 4, and 7 hours post-meal

Serum Amyloid A was obtained from blood drawn before the meal as well as 2, 4, and 7 hours post-meal. It as measured with the Vascular Injury Panel 2 Multispot Kit on an MSD Imager 2400 (both Meso Scale Discovery, Rockville, MD, USA), following kit instructions.

Change in Intercellular adhesion molecule-1Blood samples were obtained before the meal (baseline) as well as 2, 4, and 7 hours post-meal

sICAM-1 was obtained from blood drawn before the meal as well as 2, 4, and 7 hours post-meal. It was measured with the Vascular Injury Panel 2 Multispot Kit on an MSD Imager 2400 (both Meso Scale Discovery, Rockville, MD, USA), following kit instructions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath